Roles of arrest-defective protein 1225 and hypoxia-inducible factor 1α in tumor growth and metastasis

Journal of the National Cancer Institute

Volumn 102, Issue 6, 2010, Pages 426-442

  Lee, Mi Ni ^a   Lee, Shi Nai ^a   Kim, Se Hee ^b,i   Kim, Bora ^a   Jung, Bo Kyung ^b   Seo, Ji Hae ^b   Park, Ji Hyeon ^b   Choi, Jae Hoon ^a,j   Yim, Sun Hee ^a   Lee, Mi Ran ^a   Park, Jong Gil ^a,b   Yoo, Ji Young ^a   Kim, Jeong Hun ^d,e   Lee, Seung Taek ^f   Kim, Hwan Mook ^g   Ryeom, Sandra ^h   Kim, Kyu Won ^b,c   Oh, Goo Taeg ^a  

^a Ewha Womans University   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

^e Seoul National University Hospital   (South Korea)

^f Yonsei University   (South Korea)

^g Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j ROCKEFELLER UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ARREST DEFECTIVE PROTEIN 1A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; INTESTINE POLYP; KIDNEY; MALE; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STOMACH CANCER; TRANSGENIC MOUSE; TUMOR GROWTH;

ACETYLATION; ACETYLTRANSFERASES; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTESTINAL POLYPS; LUNG NEOPLASMS; LYSINE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MICE, TRANSGENIC; MICROCIRCULATION; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77949943221     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq026     Document Type: Article

References (27)

1. Mullen JR, Kayne PS, Moerschell RP, et al. Identifcation and characterization of genes and mutants for an N-terminal acetyltransferase from yeast. EMBO J. 1989;8(7):2067-2075.
2. Lee FJ, Lin LW, Smith JA. N alpha acetylation is required for normal growth and mating of Saccharomyces cerevisiae. J Bacteriol. 1989;171(11):5795- 5802.
3. Whiteway M, Freedman R, Van Arsdell S, Szostak JW, Thorner J. The yeast ARD1 gene product is required for repression of cryptic mating-type information at the HML locus. Mol Cell Biol. 1987;7(10):3713-3722.
4. Whiteway M, Szostak JW. The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathways. Cell. 1985;43(2, pt 1):483-492.
5. Jeong JW, Bae MK, Ahn MY, et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell. 2002;111(5):709-720.
6. Kim SH, Park JA, Kim JH, et al. Characterization of ARD1 variants in mammalian cells. Biochem Biophys Res Commun. 2006;340(2):422-427.
7. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3(10):721-732.
8. Masson N, Willam C, Maxwell PH, Pugh CW, Ratcliffe PJ. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 2001;20(18):5197-5206.
9. Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxyl-ation. Science. 2001;292(5516):468-472.
10. Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292(5516):464-468.
11. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-protea-some pathway. J Biol Chem. 1999;274(10):6519-6525.
12. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29(6 suppl 16):15-18.
13. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249-257.
14. Detmar M. Tumor angiogenesis. J Investig Dermatol Symp Proc. 2000;5(1):20-23.
15. Ellis LM, Fidler IJ. Angiogenesis and metastasis. Eur J Cancer. 1996;32A(14):2451-2460.
16. Ellis LM, Takahashi Y, Liu W, Shaheen RM. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist. 2000;5(suppl 1):11-15.
17. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angio-genic switch during tumorigenesis. Cell. 1996;86(3):353-364.
18. Kuwai T, Kitadai Y, Tanaka S, et al. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer. 2003;105(2):176-181.
19. Easwaran V, Lee SH, Inge L, et al. beta-Catenin regulates vascular endo-thelial growth factor expression in colon cancer. Cancer Res. 2003;63(12):3145-3153.
20. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182-1186.
21. Korsisaari N, Kasman IM, Forrest WF, et al. Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min mice. Proc Natl Acad Sci USA. 2007;104(25):10625-10630.
22. Gutierrez LS, Suckow M, Lawler J, Ploplis VA, Castellino FJ. Thrombospondin 1\a regulator of adenoma growth and carcinoma progression in the APC(Min/+) mouse model. Carcinogenesis. 2003;24(2): 199-207.
23. Oshima M, Murai N, Kargman S, et al. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specifc cyclooxyge-nase-2 inhibitor. Cancer Res. 2001;61(4):1733-1740.
24. Senger DR, Van de Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 1993; 12(3-4):303-324.
25. Roskoski R Jr. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol. 2007;62(3):179-213.
26. Yoo YG, Kong G, Lee MO. Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1. EMBO J. 2006;25(6):1231-1241.
27. Chang CC, Lin MT, Lin BR, et al. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angio-genesis. J Natl Cancer Inst. 2006;98(14):984-995.